These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1097 related items for PubMed ID: 23993293

  • 1. Impact of contrast-induced acute kidney injury on outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Kume K, Yasuoka Y, Adachi H, Noda Y, Hattori S, Araki R, Kohama Y, Imanaka T, Matsutera R, Kosugi M, Sasaki T.
    Cardiovasc Revasc Med; 2013; 14(5):253-7. PubMed ID: 23993293
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry.
    Tsai TT, Patel UD, Chang TI, Kennedy KF, Masoudi FA, Matheny ME, Kosiborod M, Amin AP, Messenger JC, Rumsfeld JS, Spertus JA.
    JACC Cardiovasc Interv; 2014 Jan; 7(1):1-9. PubMed ID: 24456715
    [Abstract] [Full Text] [Related]

  • 4. Association of radial versus femoral access with contrast-induced acute kidney injury in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Kolte D, Spence N, Puthawala M, Hyder O, Tuohy CP, Davidson CB, Sheldon MW, Laskey WK, Abbott JD.
    Cardiovasc Revasc Med; 2016 Dec; 17(8):546-551. PubMed ID: 27566903
    [Abstract] [Full Text] [Related]

  • 5. Acute Kidney Injury After Primary Angioplasty: Is Contrast-Induced Nephropathy the Culprit?
    Caspi O, Habib M, Cohen Y, Kerner A, Roguin A, Abergel E, Boulos M, Kapeliovich MR, Beyar R, Nikolsky E, Aronson D.
    J Am Heart Assoc; 2017 Jun 24; 6(6):. PubMed ID: 28647690
    [Abstract] [Full Text] [Related]

  • 6. Contrast Volume to Glomerular Filtration Ratio and Acute Kidney Injury among ST-Segment Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Intervention.
    Zahler D, Rozenfeld KL, Merdler I, Peri Y, Shacham Y.
    Cardiorenal Med; 2020 Jun 24; 10(2):108-115. PubMed ID: 31801134
    [Abstract] [Full Text] [Related]

  • 7. Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Andò G, Morabito G, de Gregorio C, Trio O, Saporito F, Oreto G.
    Catheter Cardiovasc Interv; 2013 Nov 15; 82(6):878-85. PubMed ID: 23703775
    [Abstract] [Full Text] [Related]

  • 8. B-type natriuretic peptide and risk of contrast-induced acute kidney injury in acute ST-segment-elevation myocardial infarction: a substudy from the HORIZONS-AMI trial.
    Jarai R, Dangas G, Huber K, Xu K, Brodie BR, Witzenbichler B, Metzger DC, Radke PW, Yu J, Claessen BE, Genereux P, Mehran R, Stone GW.
    Circ Cardiovasc Interv; 2012 Dec 15; 5(6):813-20. PubMed ID: 23192919
    [Abstract] [Full Text] [Related]

  • 9. The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST-segment elevation acute myocardial infarction.
    Mager A, Vaknin Assa H, Lev EI, Bental T, Assali A, Kornowski R.
    Catheter Cardiovasc Interv; 2011 Aug 01; 78(2):198-201. PubMed ID: 20949583
    [Abstract] [Full Text] [Related]

  • 10. Effect of continuous use of metformin on kidney function in diabetes patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Yu Q, Zhu JJ, Liu WX.
    BMC Cardiovasc Disord; 2020 Apr 21; 20(1):187. PubMed ID: 32316910
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the preventive efficacy of rosuvastatin versus atorvastatin in post-contrast acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Dai Y, Huang J, Zeng L, Huang Z, Duan C, Shao S, Chen H, Xue L, Chen J, Tan N, He P, Liu Y, Yu D.
    Biomed Pharmacother; 2020 Aug 21; 128():110336. PubMed ID: 32521452
    [Abstract] [Full Text] [Related]

  • 12. Impact of Serum Albumin Levels on Contrast-Induced Acute Kidney Injury in Patients With Acute Coronary Syndromes Treated With Percutaneous Coronary Intervention.
    Murat SN, Kurtul A, Yarlioglues M.
    Angiology; 2015 Sep 21; 66(8):732-7. PubMed ID: 25260710
    [Abstract] [Full Text] [Related]

  • 13. Procalcitonin as an Early Predictor of Contrast-Induced Acute Kidney Injury in Patients With Acute Coronary Syndromes Who Underwent Percutaneous Coronary Intervention.
    Kurtul A, Murat SN, Yarlioglues M, Duran M, Ocek AH, Celik IE, Kilic A, Koseoglu C, Oksuz F, Baris VO.
    Angiology; 2015 Nov 21; 66(10):957-63. PubMed ID: 25688117
    [Abstract] [Full Text] [Related]

  • 14. Hyperuricemia Is an Independent Predictor of Contrast-Induced Acute Kidney Injury and Mortality in Patients Undergoing Percutaneous Coronary Intervention.
    Guo W, Liu Y, Chen JY, Chen SQ, Li HL, Duan CY, Liu YH, Tan N.
    Angiology; 2015 Sep 21; 66(8):721-6. PubMed ID: 25616679
    [Abstract] [Full Text] [Related]

  • 15. Predictors of outcomes of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with chronic kidney disease.
    Kim JH, Yang JH, Choi SH, Song YB, Hahn JY, Choi JH, Lee SH, Gwon HC.
    Am J Cardiol; 2014 Dec 15; 114(12):1830-5. PubMed ID: 25438909
    [Abstract] [Full Text] [Related]

  • 16. Left ventricular end diastolic pressure and contrast-induced acute kidney injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Lima FV, Singh S, Parikh PB, Gruberg L.
    Cardiovasc Revasc Med; 2018 Sep 15; 19(6S):16-20. PubMed ID: 29929842
    [Abstract] [Full Text] [Related]

  • 17. Effect of a Contrast Modulation System on Contrast Media Use and the Rate of Acute Kidney Injury After Coronary Angiography.
    Mehran R, Faggioni M, Chandrasekhar J, Angiolillo DJ, Bertolet B, Jobe RL, Al-Joundi B, Brar S, Dangas G, Batchelor W, Prasad A, Gurm HS, Tumlin J, Stone GW.
    JACC Cardiovasc Interv; 2018 Aug 27; 11(16):1601-1610. PubMed ID: 30139467
    [Abstract] [Full Text] [Related]

  • 18. Elevation of urinary liver-type fatty acid-binding protein as predicting factor for occurrence of contrast-induced acute kidney injury and its reduction by hemodiafiltration with blood suction from right atrium.
    Katoh H, Nozue T, Kimura Y, Nakata S, Iwaki T, Kawano M, Kawashiri MA, Michishita I, Yamagishi M.
    Heart Vessels; 2014 Mar 27; 29(2):191-7. PubMed ID: 23604313
    [Abstract] [Full Text] [Related]

  • 19. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial).
    Bolognese L, Falsini G, Schwenke C, Grotti S, Limbruno U, Liistro F, Carrera A, Angioli P, Picchi A, Ducci K, Pierli C.
    Am J Cardiol; 2012 Jan 01; 109(1):67-74. PubMed ID: 21943940
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of neutrophil gelatinase-associated lipocalin and cystatin C as biomarkers of acute kidney injury after ST-segment elevation myocardial infarction treated by percutaneous coronary intervention.
    Nguyen LS, Spagnoli V, Kerneis M, Hauguel-Moreau M, Barthélémy O, Collet JP, Montalescot G, Silvain J.
    Arch Cardiovasc Dis; 2019 Mar 01; 112(3):180-186. PubMed ID: 30639197
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.